RLS Global (publ) change Certified Adviser to Redeye AB

RLS Global AB announces today that the company will change Certified Adviser from Erik Penser Bank to Redeye AB. The transition will take place as of April 1st, 2020. The background is that RLS will gather all advice with Redeye AB.

Trading place and certified advisor
RLS Global’s shares has been listed on the Nasdaq First North since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se.
During the period 2012 - 2017, the company was listed on Aktietorget.

Contact information:
Karin Fischer, CEO RLS Global AB
Phone: +46 702 48 46 51

Eva Jagenheim, CFO RLS Global AB
E-mail: eva.jagenheim@rlsglobal.se
Phone: +46 730 23 13 57

About RLS Global AB
RLS Global AB is a medical technology company within Life Science. Based on the company's unique hypochlorite platform, RLS Global develop products for some of our most common illnesses in wound and oral care. RLS Global has a portfolio of strong brands, including ChloraSolv® and Carisolv®. The company is listed on Nasdaq First North with Erik Penser Bank as Certified Adviser, telephone +46 (0) 8 463 83 00, email: certified adviser@penser.se. Read more at www.rls.global

About Us

For many years, RLS Global has worked with Oral Care specialists, pioneering new therapies for Oral Care and their patients. We are now taking another major step toward easier and more effective care within Wound Care. We will continue to work with Healthcare Professionals to ensure to develop a treatment that further helps deliver the best care for each patient. The method is clinically proven and saves the patient a lot of suffering. Our focus is on caring for patients, developing efficient and safe products that offer gentle treatment methods.


Documents & Links